Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Dec 26, 2025 07:01AM
Dec 9, 2025 06:56AM
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 24, 2025 07:36AM Truist Securities Starts Agios Pharma (AGIO) at Buy
Nov 20, 2025 07:51AM
Nov 20, 2025 06:19AM
Nov 19, 2025 01:53PM
Nov 19, 2025 12:44PM
Oct 30, 2025 06:30AM
Oct 20, 2025 06:42AM
Oct 17, 2025 08:01AM Agios' PYRUKYND receives positive European opinion for thalassemia
Oct 17, 2025 08:00AM
Sep 5, 2025 06:44AM
Sep 5, 2025 05:02AM
Sep 4, 2025 12:08PM
Sep 4, 2025 10:23AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
Aug 5, 2025 06:34AM
Aug 4, 2025 04:01PM
Aug 4, 2025 04:01PM
Jul 31, 2025 06:30AM
Jun 16, 2025 09:36AM
Jun 10, 2025 06:37AM
May 2, 2025 07:12AM Agios Pharma (AGIO) PT Lowered to $71 at Scotiabank
May 1, 2025 06:30AM
Feb 24, 2025 06:21AM
Feb 13, 2025 06:31AM
Jan 13, 2025 12:50PM
Jan 13, 2025 07:00AM
Jan 8, 2025 07:02AM
Jan 8, 2025 07:00AM FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
Aug 2, 2024 06:21AM
Aug 1, 2024 06:31AM
May 28, 2024 10:46AM
May 28, 2024 07:10AM
May 28, 2024 07:00AM
May 28, 2024 07:00AM
May 3, 2024 06:34AM Agios Pharma (AGIO) PT Raised to $44 at RBC Capital
May 2, 2024 07:00AM
Dec 3, 2021 09:00AM
Nov 3, 2021 07:10AM
Aug 17, 2021 04:01PM
Aug 17, 2021 04:01PM
May 2, 2019 07:00AM
Feb 20, 2019 07:08AM Agios Pharma (AGIO) Announces FDA Acceptance of sNDA for TIBSOVO for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation Not Eligible for Standard Therapy
Feb 20, 2019 07:00AM

15,546 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All